Protein kinase C inhibits transcription from the RNA polymerase III promoter of the human c-myc gene

Cancer Letters

Volumn 123, Issue 2, 1998, Pages 199-205

  Xu, Guang ^a   Gai, Qiwei ^a,b   James, Calvin B L ^a  

^a OHIO UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

c myc gene; Protein kinase C; RNA polymerase III transcription

Indexed keywords

CELLULOSE PHOSPHATE; DNA DIRECTED RNA POLYMERASE III; PROTEIN KINASE C; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION;

CELL FRACTIONATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENES, MYC; HELA CELLS; HUMANS; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; RNA POLYMERASE III; TATA BOX; TETRADECANOYLPHORBOL ACETATE;

EID: 0032579320     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00425-4     Document Type: Article

References (26)

1. Bentley D.L., Brown W.L., Groudine M. Accurate TATA box-dependent polymerase III transcription from promoters of the c-myc gene in injected Xenopus oocytes. Genes Dev. 3:1989;1179-1189.
2. Chaudhary D., Miller D.M. The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter. Biochemistry. 34:1995;3438-3445.
3. Chung J., Sussman D.J., Leader P. The c-myc gene encodes superimposed RNA polymerase II and III promoters. Cell. 51:1987;1001-1008.
4. Dean N., Berk A. Ordering promoter binding of class III transcription factor TFIIIC1 and TFIIIC2. Mol. Cell. Biol. 8:1988;3017-3025.
5. Garber M.E., Panchanathan S., Fan R.S., Johnson D.L. The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate, induces specific transcription by RNA polymerase III in Drosophila Schneider cells. J. Biol. Chem. 266:1991;20598-20601.
6. Gottesfeld J.M., Wolf V.J., Dang T., Forbes D.J., Hartel P. Mitotic repression of RNA polymerase III transcription in vitro mediated by phosphorylation of a TFIIIB component. Science. 263:1994;81-84.
7. Hanson K.D., Shichiri M., Follansbee M.R., Sedivy J.M. Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol. 14:1994;5748-5755.
8. James C.B.L., Carter T.H. Activation of protein kinase c inhibits adenovirus VA gene transcription in vitro. J. Gen. Virol. 73:1992;3133-3139.
9. Kakar S.S., Roy D. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. 87:1994;85-89.
10. Kennard M.D., Kang D.C., Montgomery R.L., Butler A.P. Expression of epidermal ornithine decarboxylase and nuclear proto-oncogene in phorbol ester tumor promotion-sensitive and -resistant mice. Mol. Carcinog. 12:1995;14-22.
11. Kerppola T.K., Kane C.M. Intrinsic sites of transcription termination and pausing in the c-myc gene. Mol. Cell. Biol. 8:1988;4389-4394.
12. J.F. Kuo, Protein Kinase C, Oxford University Press, New York, 1994.
13. Levine M., Manley J.L. Transcriptional repression of eukaryotic promoters. Cell. 59:1989;405-408.
14. Manley J., Fire A., Cano A., Sharp P. DNA-dependent transcription of adenovirus genes in a soluble whole cell extract. Proc. Natl. Acad. Sci. USA. 77:1980;3855-3859.
15. Mizuta S., Takamoto S., Naoe T. Simultaneous analysis of c-myc protein expression and cell cycle with monoclonal antibody and flow cytometry. Jpn. J. Clin. Med. 50:1992;2465-2470.
16. Ragimov N., Krauskopf A., Navot N., Rotter V., Oren M., Aloni Y. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene. 8:1993;1183-1193.
17. Rigby P.W. Three in one and one in three: it all depends on TBP. Cell. 72:1993;7-10.
18. Saito H., Hayday A.C., Wiman K., Hayward W.S., Tonegawa S. Activation of the c-myc gene by translation: a model for translational control. Proc. Natl. Acad. Sci. USA. 80:1983;7476-7480.
19. Spencer C.A., Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1991;1-48.
20. Stewart T.A., Pattengale P.K., Leader P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion gene. Cell. 38:1984;627-637.
21. Sussman D.J., Chung J., Leader P. In vitro and in vivo analysis of the c-myc RNA polymerase III promoter. Nucleic Acids Res. 19:1991;5045-5052.
22. Taggart A.K., Fisher T.S., Pugh B.F. The TATA-binding protein and associated factors are components of pol III transcription factor TFIIIB. Cell. 71:1992;1015-1028.
23. Wang Y., Stumph W.E. RNA polymerase II/III transcription specificity determined by TATA box orientation. Proc. Natl. Acad. Sci. USA. 92:1995;8606-8610.
24. R.J. White, RNA Polymerase III Transcription, R.G. Landes, Austin, TX, 1994.
25. White R.J., Jackson S.P. Mechanism of TATA-binding protein recruitment to a TATA-less class III promoter. Cell. 71:1992;1041-1053.
26. Zhang C., Zhao Q., Guo S., Zhao M., Cheng S. Modification of gene expression by tumor promoters. Acta Acad. Med. Sinicae. 17:1995;11-15.